Acadia Healthcare Company, Inc. (ACHC)
USD 23.31
(2.33%)
USD 23.31
(2.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.41 Billion USD | -1.42% |
| 2022 | 1.43 Billion USD | -4.83% |
| 2021 | 1.5 Billion USD | -47.18% |
| 2020 | 2.84 Billion USD | -19.95% |
| 2019 | 3.55 Billion USD | 13.15% |
| 2018 | 3.14 Billion USD | -0.93% |
| 2017 | 3.17 Billion USD | -1.8% |
| 2016 | 3.23 Billion USD | 44.91% |
| 2015 | 2.22 Billion USD | 122.46% |
| 2014 | 1 Billion USD | 63.61% |
| 2013 | 612.56 Million USD | 44.5% |
| 2012 | 423.91 Million USD | 95.95% |
| 2011 | 216.34 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.89 Billion USD | -0.68% |
| 2024 Q1 | 1.9 Billion USD | 35.37% |
| 2024 Q3 | 1.79 Billion USD | 1.66% |
| 2023 Q3 | 1.4 Billion USD | -0.94% |
| 2023 FY | 1.41 Billion USD | -1.42% |
| 2023 Q1 | 1.49 Billion USD | 4.69% |
| 2023 Q4 | 1.41 Billion USD | 0.19% |
| 2023 Q2 | 1.42 Billion USD | -5.13% |
| 2022 FY | 1.43 Billion USD | -4.83% |
| 2022 Q4 | 1.43 Billion USD | -1.33% |
| 2022 Q3 | 1.45 Billion USD | 2.04% |
| 2022 Q2 | 1.42 Billion USD | -4.64% |
| 2022 Q1 | 1.49 Billion USD | -0.87% |
| 2021 Q2 | 1.37 Billion USD | -2.84% |
| 2021 FY | 1.5 Billion USD | -47.18% |
| 2021 Q1 | 1.41 Billion USD | -50.13% |
| 2021 Q3 | 1.34 Billion USD | -2.56% |
| 2021 Q4 | 1.5 Billion USD | 11.87% |
| 2020 FY | 2.84 Billion USD | -19.95% |
| 2020 Q1 | 3.56 Billion USD | 0.23% |
| 2020 Q3 | 3.32 Billion USD | -2.83% |
| 2020 Q4 | 2.84 Billion USD | -14.32% |
| 2020 Q2 | 3.41 Billion USD | -4.07% |
| 2019 Q3 | 3.59 Billion USD | -3.36% |
| 2019 FY | 3.55 Billion USD | 13.15% |
| 2019 Q1 | 3.75 Billion USD | 19.46% |
| 2019 Q2 | 3.72 Billion USD | -0.9% |
| 2019 Q4 | 3.55 Billion USD | -1.09% |
| 2018 Q2 | 3.14 Billion USD | -1.34% |
| 2018 FY | 3.14 Billion USD | -0.93% |
| 2018 Q3 | 3.16 Billion USD | 0.79% |
| 2018 Q1 | 3.18 Billion USD | 0.36% |
| 2018 Q4 | 3.14 Billion USD | -0.74% |
| 2017 Q2 | 3.19 Billion USD | -1.31% |
| 2017 Q1 | 3.23 Billion USD | 0.23% |
| 2017 Q4 | 3.17 Billion USD | -0.65% |
| 2017 FY | 3.17 Billion USD | -1.8% |
| 2017 Q3 | 3.19 Billion USD | -0.08% |
| 2016 Q3 | 3.63 Billion USD | 0.35% |
| 2016 Q1 | 3.53 Billion USD | 58.34% |
| 2016 FY | 3.23 Billion USD | 44.91% |
| 2016 Q4 | 3.23 Billion USD | -11.09% |
| 2016 Q2 | 3.62 Billion USD | 2.57% |
| 2015 Q1 | 2.01 Billion USD | 101.15% |
| 2015 Q4 | 2.22 Billion USD | 7.01% |
| 2015 Q3 | 2.08 Billion USD | 8.6% |
| 2015 Q2 | 1.91 Billion USD | -4.83% |
| 2015 FY | 2.22 Billion USD | 122.46% |
| 2014 Q3 | 987.14 Million USD | 240.97% |
| 2014 Q2 | 289.51 Million USD | -55.86% |
| 2014 Q1 | 655.95 Million USD | 7.08% |
| 2014 FY | 1 Billion USD | 63.61% |
| 2014 Q4 | 1 Billion USD | 1.53% |
| 2013 FY | 612.56 Million USD | 44.5% |
| 2013 Q2 | 562.18 Million USD | 19.64% |
| 2013 Q3 | 581.22 Million USD | 3.39% |
| 2013 Q4 | 612.56 Million USD | 5.39% |
| 2013 Q1 | 469.87 Million USD | 10.84% |
| 2012 Q4 | 423.91 Million USD | 48.79% |
| 2012 FY | 423.91 Million USD | 95.95% |
| 2012 Q3 | 284.91 Million USD | 59.71% |
| 2012 Q2 | 178.39 Million USD | -41.83% |
| 2012 Q1 | 306.67 Million USD | 41.75% |
| 2011 Q3 | 136.87 Million USD | 0.0% |
| 2011 Q4 | 216.34 Million USD | 58.06% |
| 2011 FY | 216.34 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Addus HomeCare Corporation | 110.39 Million USD | -1177.872% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -1477.809% |
| Amedisys, Inc. | 341.35 Million USD | -313.258% |
| Astrana Health, Inc. | 27.2 Million USD | -5084.901% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 3.065% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 636933.385% |
| biote Corp. | 25.86 Million USD | -5353.075% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -13347.674% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 12027.42% |
| COMPASS Pathways plc | -187.58 Million USD | 851.997% |
| DocGo Inc. | -12.78 Million USD | 11130.226% |
| The Ensign Group, Inc. | 1.36 Billion USD | -3.597% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 13289.864% |
| InnovAge Holding Corp. | 56.08 Million USD | -2415.031% |
| The Joint Corp. | -2.47 Million USD | 56993.678% |
| LifeStance Health Group, Inc. | 432.21 Million USD | -226.376% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 23414.462% |
| ModivCare Inc. | 1.13 Billion USD | -24.037% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -506511.983% |
| Option Care Health, Inc. | 822.56 Million USD | -71.495% |
| P3 Health Partners Inc. | 83.7 Million USD | -1585.231% |
| P3 Health Partners Inc. | 83.7 Million USD | -1585.231% |
| The Pennant Group, Inc. | 323.57 Million USD | -335.962% |
| Surgery Partners, Inc. | 2.86 Billion USD | 50.774% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 46626.023% |
| Talkspace, Inc. | -123.9 Million USD | 1238.47% |
| Talkspace, Inc. | -123.9 Million USD | 1238.47% |
| The Oncology Institute, Inc. | 86.32 Million USD | -1534.084% |
| The Oncology Institute, Inc. | 86.32 Million USD | -1534.084% |